SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech & Pharma.T.A,
BIB 70.25+0.1%4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jibacoa who wrote (122)11/26/2002 9:46:45 PM
From: Jibacoa  Read Replies (1) of 3722
 
BSMD Was up 38.89% on volume of 1,117,839 (about 36x its daily average) after it announced that the FDA has given the go ahead for the use of Embosphere in the treatment of symptomatic uterine fibroids.(That works by cutting off the blood supply to the fibroids by a local embolization )(The news were released yesterday after the market had already closed.)

The company is also considering the use of embolotherapy in the treatment of other conditions, including stress urinary incontinence and GERD.

They have about $1.34 in cash/share and the float is only 7.8M

It showed no intention on closing the early up-gap in spite of the down day on the general market.

siliconinvestor.com

But wether it will be able to make it up to the 10 level without closing today's up-gap is a different question.<g>

siliconinvestor.com

Bernard
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext